The first description of CTLA-4 abnormalities in RA-deficient Tregs dates back to 2008, when RA patients had lower CTLA-4 levels and higher internalization rates in Tregs than healthy subjects (153). This evidence concerns the gene CTLA4 and rheumatoid arthritis.